Company intelligence / Profile preview

DHS

Qiqihar, Heilongjiang, China

Ownership: Private
Development stage: Other

Overview

DHS Pharmaceutical Co., Ltd. is a China-based pharmaceutical manufacturer established in 1996 and headquartered in Qiqihar, Heilongjiang Province. The company specializes in the production of a diverse range of therapeutic products, including central muscle relaxants, analgesics, and traditional Chinese medicine (TCM) preparations. Its portfolio features products such as aspirin and phenobarbital combinations, as well as specialized TCM formulations for cardiovascular and inflammatory conditions. DHS Pharmaceutical operates as a fully integrated manufacturer, supplying medications to hospitals, pharmacies, and healthcare facilities across China.

Therapeutic areas: CardiovascularImmunologyNeurologyInfectious Diseases
Modalities: Small moleculeTraditional Chinese medicine
Industry: Biotech

Beyond the preview

Go deeper on DHS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DHS.

Explore the full profile